CASEY POWELL: Open Payments
NPI 1962868752 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 30 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $525 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $183 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, QULIPTA, REXULTI, Rybelsus, UBRELVY, MOUNJARO, OTEZLA, CARDIOMEMS.
Industry payments across AR — which companies pay providers there.
